Switzerland-based Medimaps has launched a new version of its artificial intelligence (AI)-based image processing software for osteoporosis assessment in Europe.
Trabecular Bone Score (TBS) Osteo Advanced uses AI to correct for soft tissue thickness anterior to the lumbar spine to ensure greater TBS assessment accuracy across a wide range of body types. This latest software builds on the original TBS Osteo, which was first introduced in 2012.
The new version can be centrally managed through healthcare organisations鈥� Dual-energy X-ray (DXA) scanners for bone density assessment, with workflows standardised across multiple locations.
TBS Osteo Advanced is available under a subscription model, allowing healthcare organisations to keep up to date with the latest developments in osteoporosis care.
The European launch follows its certification under the EU鈥檚 吃瓜黑料网 Regulation (EU MDR) in January 2025. The software received 510(k) clearance from the US Food and Drug Administration (FDA) in the same month and
According to Medimaps, since the US launch in 2012, TBS Osteo has been adopted by 16 of the country鈥檚 top 20 hospitals and healthcare providers.
US Tariffs are shifting - will you react or anticipate?
Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMedimaps CEO Dr Didier Hans said the updated version of TBS Osteo has been developed to provide radiologists with a maximum of clinical output with a minimum of logistics.
鈥淒esigned for seamless integration into clinical workflows, it requires no additional exam time or extra appointments 鈥� an essential advantage for busy radiology professionals,鈥� Hans said.
鈥淭BS Osteo delivers within seconds a comprehensive report combining bone mineral density (BMD) and clinical factors, providing results beyond the standard of care.鈥�
Medimaps鈥� TBS Osteo Advanced is built on its TBS iNsight engine which received EU MDR certification in 2023.
Osteoporosis weakens bones and increases the risk of bone fractures. According to the International Osteoporosis Foundation, around live with the condition. Across the EU, Switzerland, and the UK, osteoporotic fractures are projected to rise to 5.3 million annually by 2034, up from 4.9 million in 2019.
Research by the United Nations (UN) projects that the global population aged 60 and above will reach around 2.1 billion by 2050.
According to GlobalData analysis, the ageing population is set to have a profound influence on the medical device industry, with early detection and diagnosis of age-related diseases viewed as a critical determinate in improving health outcomes.
